IDiyas

For the Inventor, By the Inventor

CA

Medicago Inc.


USPTO Granted Patents = 31



Trademarks = 24

Forward Citations = 440

Loading Chart...
Loading Chart...

123 inventors (with patents filed for the assignee):

goldMedal Marc-Andre D'Aoust (23 out of 34 patents)

silverMedal Louis-Philippe Vezina (19 out of 22 patents)

bronzeMedal Manon Couture (16 out of 20 patents)

4.  Pierre-Olivier Lavoie (13 out of 21 patents)

5.  Michele Dargis (7 out of 7 patents)

6.  Nathalie Landry (7 out of 9 patents)

7.  Frederic Ors (4 out of 7 patents)

8.  Sonia Trepanier (4 out of 4 patents)

9.  Dany Paquet (3 out of 3 patents)

10.  Marc-André D'Aoust (3 out of 3 patents)

11.  Dominique Michaud (2 out of 3 patents)

12.  Frank Sainsbury (2 out of 2 patents)

13.  Daniel F Voytas (2 out of 28 patents)

14.  Thomas Stoddard (2 out of 4 patents)

15.  Luc Mathis (2 out of 6 patents)


31 patents:

1. 11884929 - CPMV enhancer elements (2024-01-30),
2. 11833200 - Method of preparing plant-derived proteins (2023-12-05),
3. 11826419 - Method of preparing plant-derived VLPs (2023-11-28),
4. 11759512 - Modified norovirus VP1 proteins and VLPs comprising modified norovirus VP1 proteins (2023-09-19),
5. 11608361 - Norovirus fusion proteins and VLPS comprising norovirus fusion proteins (2023-03-21),
6. 11602558 - Modified norovirus VP1 proteins and VLPS comprising modified norovirus VP1 proteins (2023-03-14),
7. 11576317 - Mutantplant or cell with reduced XylT and FucT (2023-02-14),
8. 11555198 - Method for making nicotiana plants with mutations in XylT and FucT alleles using rare-cutting endonucleases (2023-01-17),
9. 11441150 - CPMV enhancer elements (2022-09-13),
10. 11434497 - Recombinant influenza virus-like particles (VLPS) produced in transgenic plants (2022-09-06),
11. 11390878 - Increasing protein yield in plants (2022-07-19),
12. 11155581 - Increasing virus-like particle yield in plants (2021-10-26),
13. 11085049 - Influenza virus-like particle production in plants (2021-08-10),
14. 10907168 - Jasmonic acid pathway activator (2021-02-02),
15. 10590173 - Picornavirus-like particle production in plants (2020-03-17),
Medicago Inc. is a biopharmaceutical company that develops and produces vaccines and therapeutics using innovative plant-based technologies. With its expertise in plant-based recombinant protein expression and manufacturing, Medicago aims to provide cost-effective and sustainable solutions for a range of infectious diseases and other health challenges. The company's technology platform allows for rapid response to emerging threats and the ability to produce large quantities of vaccines and therapeutics. Visit their website for more information and updates on their advancements in plant-based biopharmaceuticals.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

...
31 Patents

#52 in

#420 in Canada

#20,590 in the World

...
CA

Medicago Inc.

Forward Citations = 440

123 inventors:

goldMedal Marc-Andre D'Aoust (23 out of 34 patents)

silverMedal Louis-Philippe Vezina (19 out of 22 patents)

bronzeMedal Manon Couture (16 out of 20 patents)

4.  Pierre-Olivier Lavoie (13 out of 21 patents)

5.  Michele Dargis (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com
Loading…